Eğitim Bilgileri
2001 - 2007
2001 - 2007Doktora
Marmara Üniversitesi, Sağlık Bilimleri Enstitüsü, Klinik Farmasi (Yl) (Tezli), Türkiye
1998 - 2001
1998 - 2001Yüksek Lisans
Marmara Üniversitesi, Sağlık Bilimleri Enstitüsü, Klinik Farmasi (Yl) (Tezli), Türkiye
1990 - 1995
1990 - 1995Lisans
Hacettepe Üniversitesi, Eczacılık Fakültesi, Eczacılık Pr., Türkiye
Araştırma Alanları
Sağlık Bilimleri
Akademik Ünvanlar / Görevler
2017 - Devam Ediyor
2017 - Devam EdiyorProf. Dr.
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
2011 - 2017
2011 - 2017Doç. Dr.
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
2008 - 2011
2008 - 2011Yrd. Doç. Dr.
Marmara Üniversitesi, Eczacılık Fakültesi, Eczacılık Meslek Bilimleri Bölümü
1999 - 2007
1999 - 2007Araştırma Görevlisi
Marmara Üniversitesi, Sağlık Bilimleri Enstitüsü
1996 - 1997
1996 - 1997Araştırma Görevlisi
Hacettepe Üniversitesi, Sağlık Bilimleri Enstitüsü
Yönetimsel Görevler
2014 - Devam Ediyor
2014 - Devam EdiyorErasmus Programı Kurum Koordinatörü
Marmara Üniversitesi, Eczacılık Fakültesi
Akademi Dışı Deneyim
2008 - Devam Ediyor
2008 - Devam EdiyorYardımcı Doçent
Marmara Üniversitesi Eczacılık Fakültesi Klinik Eczacılık Bilim Dalı, Yardımcı Doçent
1999 - 2007
1999 - 2007Araştırma görevlisi
Marmara Üniversitesi Eczacılık Fakültesi Klinik Eczacılık Bilim Dalı, Araştırma görevlisi
1996 - 1997
1996 - 1997Araştırma görevlisi
Hacettepe Üniversitesi Eczacılık Fakültesi Farmasotik Teknoloji Anabilim dalı, Araştırma görevlisi
1995 - 1996
1995 - 1996eczacı
eczane, eczacı
1994 - 1994
1994 - 1994stajyer
Hospital Clínic i Provincial de Barcelona, stajyer
Yönetilen Tezler
2019
2019Yüksek Lisans
Kardiyoloji servisinde yatan hastalarda ilaç kullanım değerlendirmesi ve olası medikasyon sorunlarının belirlenmesi
RABUŞ Ş. (Danışman)
F.Razi(Öğrenci)
2017
2017Doktora
The ımpact of a clinical pharmacist-led pharmaceutical care program on the management of oncology patients
RABUŞ Ş. (Danışman)
R.Muhammad(Öğrenci)
Makaleler
2025
20251. Clinical Pharmacist’s Input in Identification and Resolution of Drug-Related Problems in the Neonatal and Pediatric Intensive Care Units
Ay Z. Y., Bayraktar S., SANCAR M., Büyükkayhan D., Apikoglu S.
Clinical and Experimental Health Sciences
, cilt.15, sa.2, ss.316-323, 2025 (ESCI)
2025
20252. Introduction to accreditation in pharmacy education in Türkiye: Association for evaluation and accreditation of pharmacy education programs
Apikoglu S., SANCAR M., KİRBECİ S., Eke B., Burgaz S., Kır S., et al.
Istanbul Journal of Pharmacy
, cilt.55, sa.1, ss.39-48, 2025 (Hakemli Dergi)
2024
20243. Toplum Eczanelerinde Yaşlılarda Uygun Olmayan Reçete Kalıplarının Belirlenmesi için Geliştirilmiş Bir Klinik Karar Destek Sisteminin Değerlendirilmesi
TORUN B., APİKOĞLU Ş.
Bezmiâlem Science
, cilt.12, sa.3, ss.288-296, 2024 (ESCI)
2024
20244. Clinical pharmacist interventions in nutrition-and drug-related problems in critically ill patients with renal dysfunction: a non-randomized controlled study
ÖZGAN B., Ayhan Y. E., APİKOĞLU Ş., KARAKURT S.
Frontiers in Medicine
, cilt.11, 2024 (SCI-Expanded)
2023
20235. Assessment of the Effects of Quince Seed Mucilage and Wheat Germ Oil on Wound Healing in Rats
ÇULHA C., Gun Z. U., Selcuk A., Apikoglu S.
Clinical and Experimental Health Sciences
, cilt.13, sa.3, ss.555-561, 2023 (ESCI)
2023
20236. Assessment of chemotherapy-related educational needs of colorectal cancer patients
TEZCAN S., Tanir G. I., Yilmaz H., Memis S., Yumuk P. F., APİKOĞLU Ş.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE
, cilt.29, sa.6, ss.1387-1391, 2023 (SCI-Expanded)
2023
20237. EFFECT OF MAMMOGRAPHY IMAGING PROCEDURE ON SERUM INFLAMMATORY AND/OR TUMOR MARKER LEVELS UČINAK MAMOGRAFSKOG POSTUPKA NA SERUMSKE RAZINE UPALNIH I/ILI TUMORSKIH BILJEGA
Erdal G. S., Gemici A. A., Cikot M., Rabus S. A., Isiksacan N., Inci E., et al.
Acta Clinica Croatica
, cilt.62, sa.1, ss.201-207, 2023 (SCI-Expanded)
2022
20228. The first nationwide implementation of pharmaceutical care practices through a continuous professional development approach for community pharmacists
Apikoglu Ş., Selcuk A., Ozcan V., Balta E., Turker M., Albayrak O. D., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.44, sa.6, ss.1223-1231, 2022 (SCI-Expanded)
2022
20229. Evaluation of attitudes of patients regarding vaccine hesitancy during COVID-19: community pharmacy setting
Tezcan S., Koc G., Sari H., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.44, sa.3, ss.828, 2022 (SCI-Expanded)
2022
202210. Evaluation of patient and medication profile in the general surgery clinic
Teker S., Tezcan S., YEGEN B., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.44, sa.3, ss.828, 2022 (SCI-Expanded)
2022
202211. Evaluation of awareness and knowledge of antibiotic use of patients applying to a community pharmacy
Tezcan S., Bilgin S., Sari H., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.44, sa.3, ss.829, 2022 (SCI-Expanded)
2022
202212. A cross-sectional survey to map Clinical Pharmacy Education and Practice in Europe
Moura L., Steurbaut S., Blix H. S., Addison B., RABUŞ Ş., Mota-Filipe H., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.44, sa.1, ss.118-126, 2022 (SCI-Expanded)
2021
202113. Describing clinical pharmacy education and practice in Europe
Moura L., Steurbaut S., Addison B., Blix H., Apikoglu-Rabus S., Gunten V., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.43, sa.3, ss.796, 2021 (SCI-Expanded)
2020
202014. Significance of a clinical pharmacist-led comprehensive medication management program for hospitalized oncology patients
Umar R. M., Apikoglu-Rabus S., YUMUK P. F.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.42, sa.2, ss.652-661, 2020 (SCI-Expanded)
2020
202015. Mapping clinical pharmacy education in Europe
Moura L., Steurbaut S., Jordan-von Gunten V., Addison B., Apikoglu-Rabus S., Blix H. S., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.42, sa.1, ss.225, 2020 (SCI-Expanded)
2020
202016. Comparison of APACHE II, SAPS II, SAPS II expanded and GCS scoring systems in an intensive care unit in Turkey
Kocberber E. K., Kizilaslan D., Erdogan C., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.42, sa.1, ss.247-248, 2020 (SCI-Expanded)
2019
201917. A prospective study on evaluation of clinical pharmacist's interventions regarding drug-related problems in intensive care unit
Kocberber E. K., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.41, sa.1, ss.345, 2019 (SCI-Expanded)
2019
201918. Assessment of attitudes and practice of Turkish community pharmacy staff regarding skin problems using virtual patient profiles
Apikoglu-Rabus S., Kahya I., Serin M., Yildiz P.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.41, sa.1, ss.320, 2019 (SCI-Expanded)
2019
201919. An economic study of a potential therapeutic interchange regarding biosimilar products
Apikoglu-Rabus S., Arslan B., Cengiz K. N.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.41, sa.1, ss.372, 2019 (SCI-Expanded)
2019
201920. Opinions of the Syrian patients about the effect of language barriers on the quality of pharmacy services received and about the use of pictograms
Apikoglu-Rabus S., Barri R., Alsaleh A., Umar R. M.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.41, sa.1, ss.320-321, 2019 (SCI-Expanded)
2018
201821. Drug-drug interactions among hospitalized cancer patients
Umar R. M., YUMUK P. F., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.40, sa.1, ss.246-247, 2018 (SCI-Expanded)
2018
201822. Drug-related problems identified in hospitalized cancer patients
Umar R. M., YUMUK P. F., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.40, sa.1, ss.246, 2018 (SCI-Expanded)
2018
201823. Medication errors facing the hospitalized cardiovascular disease patients
Sizgen F., Apikoglu-Rabus S., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.40, sa.1, ss.246, 2018 (SCI-Expanded)
2018
201824. Pharmacists' Opinions and Attitudes Regarding the Ongoing SMART Pharmacy Program Guiding the Nationwide Implementation of Pharmaceutical Care Practices
Apikoglu-Rabus S., Cakil E., Kaya K., Ozturk O., Balta E., Turker M., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.40, sa.1, ss.227, 2018 (SCI-Expanded)
2018
201825. SMART pharmacy program: guiding the nationwide implementation of pharmaceutical care practices preliminary results of the asthma/COPD module
Apikoglu-Rabus S., Ozcan V., Balta E., Turker M., Uney A.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.40, sa.1, ss.205, 2018 (SCI-Expanded)
2018
201826. Assessment of chemotherapy-related educational needs of colorectal cancer patients
TEZCAN S., Tanir G. I., Yilmaz H., Memis S., ŞAHİN Y., YUMUK P. F., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.40, sa.1, ss.289, 2018 (SCI-Expanded)
2017
201727. Drug-drug interactions identified for cardiac transplant recipients
Apikoglu-Rabus S., Rabus M. B., Ozkan O., ŞAHİN Y., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.39, sa.1, ss.264, 2017 (SCI-Expanded)
2017
201728. Clinical pharmacists and clinical pharmacologists: colleagues or opponents?
Koluman F., Apikoglu-Rabus S.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.39, sa.1, ss.255, 2017 (SCI-Expanded)
2017
201729. Impact of a pharmaceutical care program on glycemic control, medication knowledge and medication adherence levels of type 2 diabetic patients residing at a nursing home
Saglam N., Apikoglu-Rabus S., OKUYAN B., Izzettin F. V., Yildirim N.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.39, sa.1, ss.265, 2017 (SCI-Expanded)
2017
201730. Impact of patient education on glycemic control, medication knowledge level and medication adherence of patients with type 2 diabetes
Apikoglu-Rabus S., Sero M., OKUYAN B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.39, sa.1, ss.264-265, 2017 (SCI-Expanded)
2017
201731. Type 2 diabetes risk assessment program for children and adolescents at the community pharmacy setting
Apikoglu-Rabus S., Kocberber E. K., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.39, sa.1, ss.318-319, 2017 (SCI-Expanded)
2016
201632. Drug-related problems and pharmacist interventions in a cohort of patients with asthma and chronic obstructive pulmonary disease
Apikoglu-Rabus S., Yesilyaprak G., Izzettin F. V.
RESPIRATORY MEDICINE
, cilt.120, ss.109-115, 2016 (SCI-Expanded)
2016
201633. Translation and psychometric evaluation of the Turkish version of the pharmacy students' perceptions of preparedness to provide pharmaceutical care scale.
Okuyan B., Sancar M., Ay P., Demirkan K., Apikoglu-Rabus S., Izzettin F. V.
Die Pharmazie
, cilt.71, sa.10, ss.613-616, 2016 (SCI-Expanded)
2013
201334. In vitro effects of nitric oxide donors on apoptosis and oxidative/nitrative protein modifications in ADP-activated platelets
Sener A., Egemen G., Cevik O., Yanikkaya-Demirel G., Apikoglu-Rabus S., Ozsavci D.
HUMAN & EXPERIMENTAL TOXICOLOGY
, cilt.32, sa.3, ss.225-235, 2013 (SCI-Expanded)
2013
201335. Opinion and Knowledge Towards Pharmaceutical Care Of The Pharmacists Participated in Clinical Pharmacy and Pharmaceutical Care Continuing Education Program
SANCAR M., OKUYAN B., RABUŞ Ş., İZZETTİN F. V.
Turkish Journal of Pharmaceutical Sciences , cilt.10, sa.2, ss.245-254, 2013 (Scopus)
2012
201236. Turkish pharmacists' counseling practices and attitudes regarding emergency contraceptive pills
Apikoglu-Rabus S., Clark P. M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.34, sa.4, ss.579-586, 2012 (SCI-Expanded)
2012
201237. Comparison of the protective effects of various antiulcer agents alone or in combination on indomethacin-induced gastric ulcers in rats
Izzettin F. V., SANCAR M., OKUYAN B., Apikoglu-Rabus S., Cevikbas U.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY
, cilt.64, sa.4, ss.339-343, 2012 (SCI-Expanded)
2012
201238. Influence of Platelet gamma-Glutamyltransferase on Oxidative Stress and Apoptosis in the Presence of Holo-Transferrin
Sener A., Cevik O., Yanikkaya-Demirel G., Apikoglu-Rabus S., Ozsavci D.
FOLIA BIOLOGICA
, cilt.58, sa.5, ss.193-202, 2012 (SCI-Expanded)
2011
201139. Outcomes of diabetes risk-testing performed at community pharmacy setting
Apikoglu-Rabus S., Ture Z., Sancar M., Okuyan B., Soydeger-Carli B., Yilmaz Z., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.33, sa.2, ss.401-402, 2011 (SCI-Expanded)
2011
201140. Characteristics of the drug-disease information service demanded from the community pharmacist
Apikoglu-Rabus S., Pakalpakcil O., Okuyan B., Sancar M., Soydeger-Carli B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.33, sa.2, ss.335-336, 2011 (SCI-Expanded)
2011
201141. Effect of addition of montelukast to the asthma maintenance treatment on the clinical and humanistic outcomes
Yildirim E., Apikoglu-Rabus S., Yildiz P., Sancar M., Anil B., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.33, sa.2, ss.449, 2011 (SCI-Expanded)
2011
201142. Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting
Sancar M., Akyildiz E., Okuyan B., Rabus S. A., Carli B. S., Yilmaz Z., et al.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.33, sa.2, ss.429-430, 2011 (SCI-Expanded)
2011
201143. How much do the faculty courses contribute to daily pharmacy practice?
Apikoglu-Rabus S., Sancar M., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.33, sa.2, ss.298, 2011 (SCI-Expanded)
2011
201144. Determination of knowledge and attitude of self-care among patients with hypertension
Okuyan B., Gules M., Sancar M., Rabus S. A., Carli B. S., Izzettin F. V.
INTERNATIONAL JOURNAL OF CLINICAL PHARMACY
, cilt.33, sa.2, ss.424, 2011 (SCI-Expanded)
2011
201145. Turkish pharmacy technicians' counseling practices and attitudes regarding emergency contraceptive pills
Apikoglu-Rabus S., SANCAR M., OKUYAN B., Izzettin F. V.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY
, cilt.5, sa.1, ss.60-66, 2011 (SCI-Expanded)
2011
201146. Rhabdomyolysis Secondary to Tetanus Toxoid Administration in a Patient Following Minor Laceration
Hursitoglu M., Cikrikcioglu M. A., Gundogan E., Ozkan O., Cordan I., Yigit Y., et al.
JOURNAL OF CLINICAL PHARMACOLOGY
, cilt.51, sa.1, ss.110-111, 2011 (SCI-Expanded)
2010
201047. Effect of topical insulin on cutaneous wound healing in rats with or without acute diabetes
Apikoglu-Rabus S., Izzettin F. V., Turan P., Ercan F.
CLINICAL AND EXPERIMENTAL DERMATOLOGY
, cilt.35, sa.2, ss.180-185, 2010 (SCI-Expanded)
2009
200948. Improvement of diabetes indices of care by a short pharmaceutical care program
Turnacilar M., SANCAR M., Apikoglu-Rabus S., Hursitoglu M., Izzettin F. V.
PHARMACY WORLD & SCIENCE
, cilt.31, sa.6, ss.689-695, 2009 (SCI-Expanded)
2009
200949. Comparative effectiveness of Glycyrrhiza glabra vs. omeprazole and misoprostol for the treatment of aspirin-induced gastric ulcers
SANCAR M., Hantash T., OKUYAN B., Apikoglu-Rabus S., Cirakli Z., Gulluoglu M. G., et al.
AFRICAN JOURNAL OF PHARMACY AND PHARMACOLOGY
, cilt.3, sa.12, ss.615-620, 2009 (SCI-Expanded)
2009
200950. Evaluation of the Effect of Fibrin Glue Prepared from Single Donor Plasma on Wound Healing in Rats
AKSOY H., RABUŞ Ş., URAS F., SAVCI N., ALATLI C., ERSEVEN G., et al.
Hacettepe University Journal of Pharmacy
, ss.83, 2009 (Hakemli Dergi)
2009
200951. The economic impact of a generic substitution based reimbursement system for type-2 diabetes
Apikoglu-Rabus S., Yurtseven S. P., Guler O., Soydeger B., Rabus M. B., Demircioglu S. A., et al.
PHARMACY WORLD & SCIENCE
, cilt.31, sa.1, ss.106-107, 2009 (SCI-Expanded)
2009
200952. Community pharmacists' opinion on pharmaceutical care practice in Turkey
SANCAR M., OKUYAN B., RABUŞ Ş., Izzettin F. V.
PHARMACY WORLD & SCIENCE
, cilt.31, sa.1, ss.97, 2009 (SCI-Expanded)
2009
200953. Quality of life in patients with tuberculosis
Izzettin F. V., Eminzade S., Apikoglu-Rabus S., Karagoz T.
PHARMACY WORLD & SCIENCE
, cilt.31, sa.1, ss.61-62, 2009 (SCI-Expanded)
2008
200854. Five-year follow-up of drug utilization for secondary prevention in coronary artery disease
RABUŞ Ş., Izzettin F. V., SANCAR M., Karakaya O., Kargin R., Yakut C.
PHARMACY WORLD & SCIENCE
, cilt.30, sa.6, ss.753-758, 2008 (SCI-Expanded)
2008
200855. Assessment of drug utilization profiles, attitudes and knowledge on "performance enhancing drugs'' among players of the amateur football league
Ayca B., RABUŞ Ş.
PHARMACY WORLD & SCIENCE
, cilt.30, sa.5, ss.719, 2008 (SCI-Expanded)
2008
200856. Fourth-grade pharmacy students prefer kinesthetic learning
RABUŞ Ş., Izzettin F. V.
PHARMACY WORLD & SCIENCE
, cilt.30, sa.5, ss.687, 2008 (SCI-Expanded)
2008
200857. Cardiovascular drugs: prescription profiles and the economic impact of a generic-based reimbursement system
Cinemre-Solmaz N. B., Burat K., RABUŞ Ş.
PHARMACY WORLD & SCIENCE
, cilt.30, sa.5, ss.716-717, 2008 (SCI-Expanded)
2007
200758. Massive creatine kinase increase during quetiapine and mirtazapine treatment
Rabus S. A., Izzettin F. V., Rabus M. B., Bilici M.
PHARMACY WORLD & SCIENCE
, cilt.29, sa.5, ss.460-461, 2007 (SCI-Expanded)
2007
200759. Cardiovascular drug prescription in type 2 diabetes
Izzettin F. V., Rabus S. A., Sancar M., Gebeloglu N., Hursitoglu M.
PHARMACY WORLD & SCIENCE
, cilt.29, sa.5, ss.513-514, 2007 (SCI-Expanded)
2007
200760. Effect of pharmacist-led patient education on adherence to tuberculosis treatment
Clark P. M., Karagoz T., Apikoglu-Rabus S., Izzettin F. V.
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
, cilt.64, sa.5, ss.497-506, 2007 (SCI-Expanded)
2006
200661. The effect of exercise on urinary gamma-glutamyl transferase and protein levels of volleyball players
Ayca B., Sener A., Rabus S. A., Oba R.
JOURNAL OF SPORTS MEDICINE AND PHYSICAL FITNESS
, cilt.46, sa.4, ss.623-627, 2006 (SCI-Expanded)
2006
200662. Pharmacoeconomic comparison of Helicobacter pylori eradication regimens
Sancar M., Izzettin F. V., Apikoglu-Rabus S., Besisik F., Tozun N., Dulger G.
PHARMACY WORLD & SCIENCE
, cilt.28, sa.4, ss.207-214, 2006 (SCI-Expanded)
2006
200663. Severe creatine kinase increase during quetiapine and mirtazapine treatment
Rabus S., Izzettin F., Rabus M., Bilici M.
PSYCHOPHARMACOLOGY
, cilt.185, sa.2, ss.263-264, 2006 (SCI-Expanded)
2005
200564. Cost-effectiveness of thrombolytics: a simplified model
Rabus S., Izzettin F., Sancar M., Rabus M., Kirma C., Yakut C.
PHARMACY WORLD & SCIENCE
, cilt.27, sa.3, ss.243-248, 2005 (SCI-Expanded)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
2025
20251. Akut Böbrek Hasarı Olan Krı̇tı̇k Hastada Antı̇mı̇krobı̇yal Dozlam: Bı̇r Olgu Raporu
ÖZGAN B., AYHAN Y. E., APİKOĞLU Ş., KARAKURT S.
Marmara Üniversitesi 1. Ulusal Eczacılık Kongresi (MUEFKON), Türkiye, 8 - 10 Mayıs 2025, (Özet Bildiri)
2024
20242. QUALITY OF LIFE IN GERIATRIC PATIENTS USING PROTON PUMP INHIBITORS AND NON-STEROIDAL ANTIINFLAMMATORY DRUGS
TEZCAN S., OSMANOĞLU F. B., APİKOĞLU Ş.
52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice, Krakow, Polonya, 21 - 23 Ekim 2024, (Özet Bildiri)
2024
20243. EVALUATION OF POTENTIAL SIDE EFFECTS OF ANTIPSYCHOTICS IN A COMMUNITY SETTING
TEZCAN S., BİLGİ İ. E., APİKOĞLU Ş.
52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice, Krakow, Polonya, 21 - 23 Ekim 2024, (Özet Bildiri)
2024
20244. KNOWLEDGE AND ATTITUDES OF THE PUBLIC REGARDING THE USE OF DERMOCOSMETICS IN A COMMUNITY SETTING
TEZCAN S., ÖKTEM B., APİKOĞLU Ş.
52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice, Krakow, Polonya, 21 - 23 Ekim 2024, (Özet Bildiri)
2024
20245. THE KNOWLEDGE OF RATIONAL ANTIBIOTIC USE BY INDIVIDUALS IN A COMMUNITY SETTING.
TEZCAN S., AKTAN S. Y., APİKOĞLU Ş.
52nd ESCP Symposium on Clinical Pharmacy. Implementing and scaling sustainable clinical pharmacy practice, Krakow, Polonya, 21 - 23 Ekim 2024, (Özet Bildiri)
2024
20246. The Impact Of The Clinical Pharmacist On Nutrition And Drug-Related Problems In Critically Ill Patients With Renal Dysfunction
ÖZGAN B., AYHAN Y. E., APİKOĞLU Ş., KARAKURT S.
Implementing and Scaling Sustainable Clinical Pharmacy Practice, Krakow, Polonya, 21 - 23 Ekim 2024, (Özet Bildiri)
2023
20237. PLASMA CA125 LEVELS AND ACUTE CORONARY SYNDROME: IS THERE A RELATIONSHIP WITH PROGNOSIS?
Çalışkan N. D., TEZCAN S., APİKOĞLU Ş., Çalışkan O., KARABAĞ T.
ESCP Aberdeen Symposium 2023: Innovations in Clinical Pharmacy Practice, Education and Research, Aberdeen, İngiltere, 30 Ekim - 02 Kasım 2023, (Özet Bildiri)
2023
20238. THE EFFECT OF CLINICAL PHARMACY SERVICES IN PATIENTS WITH ACUTE CORONARY SYNDROME: A RANDOMIZED CONTROLLED STUDY
TEZCAN S., Çalışkan N. D., Çalışkan O., APİKOĞLU Ş., KARABAĞ T.
ESCP Aberdeen Symposium 2023: Innovations in Clinical Pharmacy Practice, Education and Research, Aberdeen, İngiltere, 31 Ekim - 02 Kasım 2023, (Özet Bildiri)
2023
20239. THE CLINICAL PHARMACIST'S ROLE IN MEDICATION ADHERENCE AND TREATMENT SATISFACTION WITH DIRECT-ACTING ORAL ANTICOAGULANTS
YÜRÜK F. U., TEZCAN S., APİKOĞLU Ş., ÖZBİLGİN N.
ESCP Aberdeen Symposium 2023: Innovations in Clinical Pharmacy Practice, Education and Research, Aberdeen, İngiltere, 31 Ekim - 02 Kasım 2023, (Özet Bildiri)
2023
202310. DRUG-RELATED PROBLEMS IN PATIENTS WITH ATRIAL FIBRILLATION AND TYPE 2 DIABETES: INTERVENTIONS OF THE CLINICAL PHARMACIST
YÜRÜK F. U., TEZCAN S., APİKOĞLU Ş., YAĞMUR A.
ESCP Aberdeen Symposium 2023: Innovations in Clinical Pharmacy Practice, Education and Research, Aberdeen, İngiltere, 31 Ekim - 02 Kasım 2023, (Özet Bildiri)
2023
202311. EVALUATION OF DIABETES KNOWLEDGE OF PHARMACY STUDENTS
AY Z. Y., TEZCAN S., APİKOĞLU Ş.
International Multidisciplinary Symposium on Drug Research and Development - DRD 2023, İzmir, Türkiye, 4 - 06 Mayıs 2023, (Özet Bildiri)
2022
202212. Evaluation of the knowledge and attitudes toward proton pump inhibitors use of the patients at community pharmacy setting
Kırkan E., TEZCAN S., SARI H., APİKOĞLU Ş.
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care, Çek Cumhuriyeti, 19 Ekim 2022, (Özet Bildiri)
2022
202213. Evaluation of skin cancer and sun knowledge and sun protection status of the patients
TEZCAN S., Üzümağı G., SARI H., APİKOĞLU Ş.
50th ESCP Symposium on Clinical Pharmacy, Polypharmacy and ageing - highly individualized, interprofessional, person-centered care, Çek Cumhuriyeti, 19 - 21 Ekim 2022, (Özet Bildiri)
2022
202214. Determınatıon Of Qualıty Of Lıfe And Medıcatıon Adherence In Patıents Wıth Acute Coronary Syndrome
Çalışkan N. D., Çalışkan O., APİKOĞLU Ş., TEZCAN S.
Trakya Üniversiteler Birliği V. Uluslararası Sağlık Bilimleri Kongresi (UTUC 2022), Bandırma, Türkiye, 01 Aralık 2022, (Özet Bildiri)
2022
202215. EVALUATION OF ATTITUDES OF PATIENTS REGARDING VACCINE HESITANCY DURING COVID-19: COMMUNITY PHARMACY SETTING
TEZCAN S., KOÇ G., KÖSE H., APİKOĞLU Ş.
ESCP Spring Workshop 2022, Zürich, İsviçre, 28 - 29 Nisan 2022, (Özet Bildiri)
2022
202216. EVALUATION OF AWARENESS AND KNOWLEDGE OF ANTIBIOTIC USE OF PATIENTS APPLYING TO A COMMUNITY PHARMACY
TEZCAN S., BİLGİN S., KÖSE H., APİKOĞLU Ş.
ESCP Spring Workshop 2022, Zürich, İsviçre, 28 Nisan 2022, (Özet Bildiri)
2021
202117. Türkiye'de Klinik Eczacılık ve Farmasötik Bakım Konularında Yapılan Lisansüstü Tezlerin İncelenmesi
TEZCAN S., YÜRÜK F. U., RABUŞ Ş.
III.Ulusal Eczacılık Eğitimi ve Akreditasyon Kongresi, İstanbul, Türkiye, 17 - 19 Kasım 2021, (Özet Bildiri)
2020
202018. ”Diabetes Pharmacotherapy” Diyabet farmakoterapisi
RABUŞ Ş.
Kronik Hastalıklarda Akılcı İlaç Kullanımı Çalıştayı, Klinik Eczacılık Derneği, Kütahya, Türkiye, 07 Şubat 2020, (Özet Bildiri)
2019
201919. Evaluation of medication knowledge and medication use behaviors of the patients visiting community pharmacies.
RABUŞ Ş., Buyuk A.
3rd International Public Health Congress, Antalya, Türkiye, 26 - 30 Kasım 2019, (Özet Bildiri)
2019
201920. Assessment of the perceived social support and its relationship with the medication adherence of individuals with chronic disease
Kinay E., Ilik B., Sari H., Büyüker S., Buyuk A., RABUŞ Ş.
3rd International Public Health Congress, Antalya, Türkiye, 26 - 30 Kasım 2019, (Özet Bildiri)
2019
201921. The impact of a pictogram-assisted diabetes-counseling program on the outcomes of the Syrian diabetic patients
RABUŞ Ş., Alsalih A.
3rd International Public Health Congress, Antalya, Türkiye, 26 - 30 Kasım 2019, (Özet Bildiri)
2019
201922. ”Pharmaceutical care and systematic approach to treatment” Farmasötik bakım ve tedaviye sistematik yaklaşım
RABUŞ Ş.
Pharmetic Girişimci Eczacılar Derneği Polifarmasi ve Akılcı İlaç Kullanımı Sempozyumu, Eskişehir, Türkiye, 8 - 10 Kasım 2019, (Özet Bildiri)
2019
201923. ”Information sources and drug ınformation” Bilgi kaynaklarına erişim ve ilaç danışmanlığı
RABUŞ Ş.
Pharmetic Girişimci Eczacılar Derneği Polifarmasi ve Akılcı İlaç Kullanımı Sempozyumu, Eskişehir, Türkiye, 8 - 10 Kasım 2019, (Özet Bildiri)
2019
201924. Comparison of APACHE 2, SAPS 2, SAPS 2 Expanded and GCS scoring systems in an intensive care unit in Turkey
Karatas Kocberber E., Kızılaslan D., Erdogan C., RABUŞ Ş.
European Society of Clinical Pharmacy(ESCP) - 48th European Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)
2019
201925. Mapping clinical pharmacy education in Europe.
Moura L., Steurbaut S., Jordan von Gunten V., Addison B., RABUŞ Ş., Salvesen Blix H.
European Society of Clinical Pharmacy(ESCP)-48th European Symposium on Clinical Pharmacy, Ljubljana, Slovenya, 23 - 25 Ekim 2019, (Özet Bildiri)
2019
201926. ”Preventive pharmacy services at community pharmacies” Serbest eczanelerde koruyucu eczacılık hizmetleri
RABUŞ Ş.
İstanbul Eczacılık Buluşması, İstanbul, Türkiye, 11 Mayıs 2019, (Özet Bildiri)
2019
201927. ”Do weight-loss supplements really help?” Zayıflama ürünleri gerçekten etkili mi?
RABUŞ Ş.
Kadıköy Kent Konseyi, İstanbul, Türkiye, 02 Mayıs 2019, (Özet Bildiri)
2019
201928. ”Workshop on Pharmaceutical care” farmasötik bakım Çalıştayı
RABUŞ Ş.
Türk Eczacılar Birliği Gençlik Komisyonu 2.Ulusal Kongresi, Ankara, Türkiye, 22 - 24 Şubat 2019, (Özet Bildiri)
2019
201929. ”Clinical pharmacy workshop on case studies” Klinik eczacılık atölyesi
RABUŞ Ş.
Türk Eczacılar Birliği Gençlik Komisyonu 2.Ulusal Kongresi, Ankara, Türkiye, 22 - 24 Şubat 2019, (Özet Bildiri)
2019
201931. Courses on Clinical Pharmacology
RABUŞ Ş.
Bukhara State Medical Institute, 28 Ocak - 01 Şubat 2019
2019
201932. Clinical pharmacology of drugs used to treat angina
RABUŞ Ş.
Bukhara State Meical Institute, 30 Ocak 2019
2019
201933. ”Pharmaceutical Care” Farmasötik bakım
RABUŞ Ş.
Türkiye’de Kan Basıncı Kontrolünün İyileştirilmesi Projesi, Türk Eczacılar Birliği Rehber Eczanem Projesi, Hipertansiyon ve Eczacı Eğitimi, Erzincan, Türkiye, 15 Ocak 2019, (Özet Bildiri)
2018
201834. ”Metabolic Syndrome in Cancer Patients” Kanser hastalarında metabolik sendrom
RABUŞ Ş.
2.Kapsamlı Knaser Merkezlerinde Klinik Eczacılık Sempozyumu, Ankara, Türkiye, 06 Aralık 2018
2018
201835. ”Access to the right information source and rational drug use” doğru bilgi kaynağına erişim ve akılcı ilaç kullanımı
RABUŞ Ş.
2.Kapsamlı Kanser Merkezlerinde Klinik Eczacılık Sempozyumu, Ankara, Türkiye, 06 Aralık 2018
2018
201836. Economic analysis of biosimilar drugs approved in Turkey : a study covering the 2014-2017 period
RABUŞ Ş., Arslan B.
International IVEK Biotechnology Congress, İstanbul, Türkiye, 26 - 28 Kasım 2018, (Özet Bildiri)
2018
201837. Türkiye’de klinik eczacılık eğitiminin gelişimi: Marmara modeli”
SANCAR M., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., KÜÇÜKGÜZEL Ş. G.
2. Ulusal Marmara Eczacılık Kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)
2018
201838. Marmara Üniversitesi’nde eczacılıkta uzmanlık eğitimi: İlk deneyimler
SANCAR M., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., KÜÇÜKGÜZEL Ş. G.
2. Ulusal Marmara Eczacılık Kongresi, Türkiye, 14 - 16 Kasım 2018, (Özet Bildiri)
2018
201839. ”New Model of Pharmacy Service and Pharmacy in the Future” Yeni eczacılık hizmet modeli ve geleceğin eczacılığı
RABUŞ Ş.
14.Türkiye Eczacılık Kongresi, Ankara, Türkiye, 1 - 03 Kasım 2018
2018
201840. All you need to know about clinical rounds: from design to assessment.
İZZETTİN F. V., RABUŞ Ş., SANCAR M.
ESCP47th European Symposium on Clinical Pharmacy, 24 - 26 Ekim 2018
2018
201841. Opinions of the Syrian patients about the effect of language barriers on the quality of pharmacy services received and about the use of pictograms
RABUŞ Ş., Barri R., Alsaleh A., Muhammad Umar R.
European Society of Clinical Pharmacy (ESCP) - 47th European Symposium on Clinical Pharmacy, Belfast, Birleşik Krallık, 24 - 26 Ekim 2018, (Özet Bildiri)
2018
201842. Prospective study of evaluation of clinical pharmacist’xxs interventions about drug related problems in intensive care unit
RABUŞ Ş., Karatas Kocberber E.
European Society of Clinical Pharmacy (ESCP) - 47th European Symposium on Clinical Pharmacy, Belfast, Birleşik Krallık, 24 - 26 Ekim 2018, (Özet Bildiri)
2018
201843. An economic study of a potential therapeutic interchange regarding biosimilar products
RABUŞ Ş., Aslan B., Cengiz K.
European Society of Clinical Pharmacy(ESCP) - 47th European Symposium on Clinical Pharmacy, Belfast, Birleşik Krallık, 24 - 26 Ekim 2018, (Özet Bildiri)
2018
201844. Assessment of attitudes and practice of Turkish community pharmacy staff regarding skin problems using virtual patient profiles
RABUŞ Ş., Kahya I., Serin M., Yildiz P.
European Society of Clinical Pharmacy (ESCP) - 47th European Symposium on Clinical Pharmacy, Belfast, Birleşik Krallık, 24 - 26 Ekim 2018, (Özet Bildiri)
2018
201845. Panel Türkiye de klinik eczacılık ve farmasötik bakım doğru anlaşıldı mı Eğitim uygulamalar ve araştırmalara bakış
RABUŞ Ş.
9. Türkiye Eczacılık Kongresi, Türkiye, 13 - 16 Ekim 2018, (Tam Metin Bildiri)
2018
201846. Smart Pharmacy:Guiding the Nationwide Implementation of Pharmaceutical Care Practices
RABUŞ Ş.
20th EPSA Summer University, 23 - 29 Temmuz 2018
2018
201848. ”Clinical Reasoning at Community Pharmacies” Serbest Eczanelerde Klinik Gerekçelendirme
RABUŞ Ş.
1.Marmara Klinik Eczacılık Günleri, Türkiye, 14 Mayıs 2018
2018
201849. ”SMART Pharmacy Program” Meslek hakkına giden yolda Türk Eczacıları Birliği Rehber Eczanem Programı
RABUŞ Ş.
Medipol Üniversitesi Ulusal Algı ve Farkındalık Eczacılık Kongresi, İstanbul, Türkiye, 4 - 06 Mayıs 2018
2018
201850. Drug Interaction with commonly used herbal products
RABUŞ Ş.
International Traditional and Complimentary Medicine Congress, İstanbul, Türkiye, 19 - 22 Nisan 2018, (Özet Bildiri)
2017
201751. ”Drug Information and Sources of Information” İlaç danışmanlığı ve bilgi kaynaklarına erişim
RABUŞ Ş.
Hastane Eczacılığında Kanser Olguları Çalıştayı, Tekirdağ, Türkiye, 10 - 11 Kasım 2017
2017
201752. Assessment of chemotherapy-related educational needs of colorectal cancer patients
TEZCAN S., TANIR G. İ., YILMAZ H., MEMİŞ S., ŞAHİN Y., YUMUK P. F., et al.
46th ESCP Symposium on Clinical Pharmacy Science meets practice - towards evidence-based clinical pharmacy services, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)
2017
201753. SMART Pharmacy Team. Pharmacists’ Opinions and Attitudes Regarding the Ongoing SMART Pharmacy Program Guiding the Nationwide Implementation of Pharmaceutical Care Practices.
RABUŞ Ş., Çakıl E., Kaya K., Öztürk Ö., Balta E., Türker M., et al.
46th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Heidelberg, Germany, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)
2017
201754. SMART Pharmacy Program: Guiding The Nationwide Implementation of Pharmaceutical Care Practices – Preliminary Results of the Asthma/COPD Module.
RABUŞ Ş., Ozcan V., Balta E., Turker M., Üney A.
46th European Society ofClinical Pharmacy (ESCP) Annual Symposium, Heidelberg, Germany, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)
2017
201755. Drug-drug interactions among hospitalized cancer patients.
Muhammad Umar R., YUMUK P. F., RABUŞ Ş.
46th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Heidelberg, Germany., 9 - 11 Ekim 2017, (Özet Bildiri)
2017
201756. Drug-Related Problems Identified in Hospitalized Cancer Patients
Muhammad Umar R., YUMUK P. F., RABUŞ Ş.
46th European Society of Clinical Pharmacy (ESCP) AnnualSymposium, Heidelberg, Germany, 9 - 11 Ekim 2017, (Özet Bildiri)
2017
201757. Medication errors facing the hospitalized cardiovascular disease patients
Sizgen F., RABUŞ Ş., İZZETTİN F. V.
46th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Heidelberg, Germ, Heidelberg, Almanya, 9 - 11 Ekim 2017, (Özet Bildiri)
2017
201758. Doğru bilgi kaynağına erişim ve akılcı ilaç kullanımı,
RABUŞ Ş.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu, Bodrum, Türkiye, 18 - 21 Mayıs 2017
2017
201759. Hasta izlemi ve klinik uygulama becerileri interaktif atölye çalışması,
İZZETTİN F. V., SANCAR M., RABUŞ Ş., OKUYAN B.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu, Bodrum, Türkiye, 18 - 21 Mayıs 2017
2017
201760. ”SMART Pharmacy Program” SMART Eczane Programı
RABUŞ Ş.
Ekafarma Eczacılık Zirvesi,İstanbul Üniversitesi Eczacılık Fakültesi, İstanbul, Türkiye, 08 Mayıs 2017
2017
201761. SMART Eczane Programı: Eczaneler Değişiyor, Toplum Sağlığı Gelişiyor!
Üney A., RABUŞ Ş., Balta E., Türker M., Özcan V.
3. Uluslararası İlaç Ve Eczacılık Kongresi, İstanbul, Türkiye., 26 - 29 Nisan 2017, (Özet Bildiri)
2017
201762. Kronik Hastalıklarda Eczacı Danışmanlığı
RABUŞ Ş.
3. Uluslararası İlaç ve Eczacılık Kongresi, 26 - 29 Nisan 2017
2017
201763. Smart Eczane Projesi Samsun Bölge Uygulamaları.
Öztürk Ö., Üney A., Bulut P., Saral A., Sakoğlu E., Turgut Ç., et al.
3. Uluslararası İlaç Ve Eczacılık Kongresi, İstanbul, Türkiye., İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)
2017
201764. Smart Eczane Programı Antalya Eczacı Odası Uygulaması.
Çakıl E., Karadağ A., Biçer V., Göl T., Üney A., RABUŞ Ş.
3. Uluslararası İlaç Ve Eczacılık Kongresi, İstanbul, Türkiye., 26 - 29 Nisan 2017, (Özet Bildiri)
2017
201765. Smart Eczane Programı 29. Bölge Manisa Eczacı Odası Uygulaması.
Kaya K., Arslan C., Öncü Ağar H., Üney A., RABUŞ Ş.
3. Uluslararası İlaç Ve Eczacılık Kongresi, İstanbul, Türkiye., İstanbul, Türkiye, 26 - 29 Nisan 2017, (Özet Bildiri)
2017
201766. ”Panel: Clinical Pharmacy Practices” Panel: klinik eczacılık uygulamalarında neredeyiz?-2: Uygulamaların içinden
RABUŞ Ş.
Ulusal Klinik Eczacılık ve Farmasötik Bakım Kongresi, Antalya, Türkiye, 9 - 12 Şubat 2017
2017
201767. ”Workshop: Technical Skills in Pharmacy Practice(insulin injection, inhaler use, glucometer use, blood pressure measurements,etc)” Eczacılık uygulamalarında teknik beceriler(insülin enjeksiyonu, inhaler kullanımı, KB ölçümü, glukometre kullanımı,vb)
RABUŞ Ş., Tanır G. İ.
Ulusal Klinik Eczacılık ve Farmasötik Bakım Kongresi, Antalya, Türkiye, 9 - 12 Şubat 2017
2017
201768. ”Type 2 Diabetes in Children and adolescents” Çocuklarda ve Adölesanlarda tip 2 diyabet
RABUŞ Ş.
Ulusal Klinik Eczacılık ve Farmasötik Bakım Kongresi, Antalya, Türkiye, 9 - 12 Şubat 2017
2016
201669. ”Clinical pharmacy practice in chronic disease management” Kronik hastalıklarda klinik eczacılık uygulamaları
RABUŞ Ş.
13.Türkiye Eczacılık Kongresi, İstanbul, Türkiye, 21 - 24 Aralık 2016
2016
201670. Drug drug interactions identified for cardiac transplant recipients
RABUŞ Ş., RABUŞ M. B., ÖZKAN Ö., ŞAHİN Y., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)
2016
201671. Type 2 diabetes in children and adolescents
RABUŞ Ş.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)
2016
201672. Clinical Pharmacists and Clinical Pharmacologists Colleagues or Opponents
RABUŞ Ş., KOLUMAN F.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)
2016
201673. Type 2 diabetes risk assessment program for children and adolescents at the community pharmacy setting
RABUŞ Ş., KARATAŞ KOÇBERBER E., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, Oslo, Norveç, 5 - 07 Ekim 2016, (Özet Bildiri)
2016
201674. Impact of a pharmaceutical care program on glycemic control medication knowledge and medication adherence levels of type 2 diabetic patients residing at a nursing home
sağlam n., RABUŞ Ş., OKUYAN B., İZZETTİN F. V., yıldırım n.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri)
2016
201675. Impact of Patient Education on Glycemic Control Medication Knowledge Level and Medication Adherence of Patients with Type 2 Diabetes
RABUŞ Ş., şero m., OKUYAN B., İZZETTİN F. V.
45th European Society of Clinical Pharmacy (ESCP) Annual Symposium, 5 - 07 Ekim 2016, (Özet Bildiri)
2016
201676. ”Rational drug use at community pharmacy” Serbest eczanede akılcı ilaç kullanımı
RABUŞ Ş.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu-2, Antalya, Türkiye, 26 - 29 Mayıs 2016
2016
201677. ”Clinical pharmacy: resurrection” Klinik eczacılık: Diriliş
RABUŞ Ş.
Pharmankara-Ankara Üniversitesi Öğrenci Kongresi, Ankara, Türkiye, 29 - 30 Nisan 2016
2015
201578. ”Pharmacist’s role in diabetes management” Diyabet tedavisinde eczacının rolü/ Diyabet ve hipertansiyonda eczacının rolü
RABUŞ Ş.
Pharmaclass Serbest Eczacılar için Hasta-Odaklı Yaz Okulu,Bodrum, Muğla, Türkiye, 3 - 06 Eylül 2015
2015
201579. ”Patient-focused services at the community pharmacies and rational drug use” Eczanelerde hasta odaklı hizmetler ve akılcı ilaç kullanımı
RABUŞ Ş.
Pharmaclass Seerbest Eczaneler için Hasta-Odaklı Yaz Okulu,Bodrum, Muğla, Türkiye, 3 - 06 Eylül 2015
2015
201580. ”Pharmacist’s role in rational drug use” akılcı ilaç kullanımı ve eczacının rolü
RABUŞ Ş.
Hatay Eczacı Odası, Hatay, Türkiye, 09 Temmuz 2015
2015
201581. ”what do we know for food-drug interactions?” Gıda ilaç etkileşimleri hakkında ne biliyoruz?
RABUŞ Ş.
2.İstanbul Eczacılık Kongresi, İstanbul, Türkiye, 22 - 24 Mayıs 2015
2014
201482. ”Pharmacist role in cardiometabolic disease management” Kardiyometabolik hastalık yönetiminde eczacının rolü/ Kronik hastalarda eczacı desteği ve eczacının danışmanlık yönü
RABUŞ Ş.
İVEK Uluslararası İlaç ve Eczacılık Kongresi, İstanbul, Türkiye, 28 - 30 Kasım 2014
2014
201483. ”Drug information service at community pharmacy?” Eczanede klinik eczacılık hizmetleri-İlaç danışmanlık hizmetini nasıl verebiliriz?
RABUŞ Ş.
12.Türkiye Eczacılık Kongresi, Ankara, Türkiye, 25 - 27 Eylül 2014
2014
201484. Clinical pharmacist counseling in cardiometabolic diseases
RABUŞ Ş.
4th International Meeting on PharmacyPharmaceutical Sciences(IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014
2014
201485. Development and validation of the Turkish Diabetes-Spesific quality of life scale
RABUŞ Ş., Yazici D., Hursitoglu M., Mete F., Demirtunc R., İZZETTİN F. V.
4th International Meeting on Pharmacy Pharmaceutical Sciences (IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2014
201486. A model program for obesity prevention and control in community pharmacy
RABUŞ Ş., Gultekin G., İZZETTİN F. V.
4th International Meeting on Pharmacy pharmaceutical Sciences (IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2014
201487. Assessment of the effects of quince seed mucilage and wheat germ oil on wound healing in rats
Atalay C., RABUŞ Ş., İZZETTİN F. V.
4th International Meeting on Pharmacy Pharmaceutical Sciences (IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2014
201488. Assessment of and interventions to solve drug related problems in patients with asthma and chronic obstructive pulmonary disease (COPD) that is not fully controlled
Yeşilyaprak G., RABUŞ Ş., İZZETTİN F. V.
4 th International Meeting on Pharmacy Pharmaceutical Sciences (IMPSS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2014
201489. Mitral ring annuloplasty in a patient with idiopathic thrombocytopenic purpura successfully managed with corticosteroids
RABUŞ M. B., RABUŞ Ş., Songur M., Yerlikhan O., Zeybek R.
4th International Meeting on Pharmacy Pharmaceutical Sciences (IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2014
201490. Clinical pharmacotherapy education by problem-based learningin clinical pharmacy courses
RABUŞ Ş.
4th International Meeting on Pharmacy Pharmaceutical Sciences (IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2014
201491. Classification for drug-related problems: Turkish translation and adaptation of the PCNE-DRP classification (6.2)
RABUŞ Ş., Yeşilyaprak G.
4th International Meeting on Pharmacy Pharmaceutical Sciences (IMPPS-4), İstanbul, Türkiye, 18 - 21 Eylül 2014, (Özet Bildiri)
2012
201292. Tacrolimus induced encephalopathy in a heart transplant recipient in the absence of overdose
RABUŞ M. B., Atasoy B., RABUŞ Ş., Cayhan B., Fedakar A., Balkanay M.
8th International Congress of Update in Cardiology and Cardiovascular Surgery (UCCVS), Antalya, Türkiye, 1 - 04 Mart 2012, (Özet Bildiri)
2011
201193. Klinik Eczacılık ve Farmasötik Bakım
RABUŞ Ş.
Yeditepe Yedikonu Öğrenci Kongresi, İstanbul, Türkiye, 14 - 16 Ekim 2011, (Tam Metin Bildiri)
2011
201194. Cut off point of waist circumference for the diagnosis of metabolic syndrome in Turkish population
Hursitoglu M., Tukek T., Cikrikcioglu M., Yigit Y., Cakirca M., Zeren G., et al.
10th Congress of the European Federation of Internal Medicine, Athens, Yunanistan, 5 - 08 Ekim 2011, (Özet Bildiri)
2010
201095. Cardiovascular disease risk assessment among patients with hyperlipidemia at a community pharmacy setting
SANCAR M., AKYILDIZ E., OKUYAN B., RABUŞ Ş., SOYDEĞER CARLI B., YILMAZ Z., et al.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33
2010
201096. Determination of knowledge and attitude of self care among patients with hypertension
OKUYAN B., GÜLEŞ M., SANCAR M., RABUŞ Ş., SOYDEĞER CARLI B., İZZETTİN F. V.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33
2010
201097. How much do the faculty courses contribute to daily pharmacy practice
RABUŞ Ş., SANCAR M., İZZETTİN F. V.
Proceedings: 39th European Symposium on Clinical Pharmacy Lyon, France, 21-23 October 2010., Lyon, Fransa, 21 - 23 Ekim 2010, (Özet Bildiri)
2010
201098. Characteristics of the drug disease information service demanded from the community pharmacist
RABUŞ Ş., PAKALPAKCİL O., OKUYAN B., SANCAR M., SOYDEGER CARLI B., İZZETTİN F. V.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33
2010
201099. Outcomes of diabetes risk testing performed at community pharmacy setting
RABUŞ Ş., TURE Z., SANCAR M., OKUYAN B., SOYDEGER CARLI B., YILMAZ Z., et al.
39th European Symposium on Clinical Pharmacy: Clinical Pharmacy at the Front Line of Innovations, 21 - 23 Ekim 2010, cilt.33
2010
2010100. Effect of addition of montelukast to the asthma maintenance treatment on the clinical and humanistic outcomes
YILDIRIM E., RABUŞ Ş., Yildiz P., SANCAR M., ANIL B., İZZETTİN F. V.
Proceedings: 39th European Symposium on Clinical Pharmacy Lyon, France, 21-23 October 2010., Lyon, Fransa, 21 - 23 Ekim 2010, (Özet Bildiri)
2010
2010101. Dicle Üniversitesi Tıp Fakültesi Hastanesi nde tedavi gören diyabet hastalarının farmasötik bakım ihtiyaçlarının belirlenmesi
ÇİÇEK M., SANCAR M., RABUŞ Ş., OKUYAN B., GÖKALP D., İZZETTİN F. V.
10. Türkiye Eczacılık Kongresi, Türkiye, 30 Eylül - 03 Ekim 2010
2010
2010102. Workshop on pharmaceutical care in diabetes
İZZETTİN F. V., SANCAR M., RABUŞ Ş., OKUYAN B.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010
2010
2010103. The biochemical assessment of the effectsof Nigella sativa oil on cutaneous wound healing in rats
AKSOY H. Z., RABUŞ Ş., SANCAR M., OKUYAN B., URAS F., İZZETTİN F. V.
Third International Meeting on Pharmacy and Pharmaceutical Sciences Istanbul Turkey 2010, 09 Haziran 2010, (Özet Bildiri)
2010
2010104. Evaluation of dietary supplement consumption at community pharmacy setting
OKUYAN B., KAYA E., SANCAR M., RABUŞ Ş., SOYDEĞER CARLI B., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010
2010
2010105. Assessment of the 5th grade pharmacy students opinions on the first time held pharmacy practice I course of the second cycle
SOYDEĞER CARLI B., OKUYAN B., RABUŞ Ş., SANCAR M., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010
2010
2010106. The biochemical assessment of the effects of Nigella sativa oil on cutaneous wound healing in rats
AKSOY H., RABUŞ Ş., SANCAR M., OKUYAN B., URAS F., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010
2010
2010107. Perceived job satisfaction of Turkish pharmacists
RABUŞ Ş., KONCAGÜL M. İ., OKUYAN B., SOYDEĞER CARLI B., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010
2010
2010108. Turkish certified pharmacy technicians counseling practices and attitudes regarding emergency contraceptive pills
RABUŞ Ş., SANCAR M., OKUYAN B., İZZETTİN F. V.
Third International Meeting on Pharmacy & Pharmaceutical Sciences (IMPPS-3), 9 - 12 Haziran 2010
2009
2009109. Discrepancy between university education and daily pharmacy practice in Turkey
RABUŞ Ş.
5th European Meeting of Women Pharmacists, Leipzig, Almanya, 4 - 06 Eylül 2009, (Tam Metin Bildiri)
2009
2009110. Factors Affecting Quality of Life in Type 2 Diabetes
RABUŞ Ş.
9th Interntional Symposium of Pharmaceutical Sciences, Ankara, Türkiye, 23 Haziran - 26 Eylül 2009, (Tam Metin Bildiri)
2009
2009111. Clinical Pharmacy Workshop and Patient Centred Teaching
İZZETTİN F. V., DEMİRKAN S. K., SANCAR M., RABUŞ Ş.
9th International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 23 - 26 Haziran 2009, (Tam Metin Bildiri)
2009
2009112. Assessment of a Clinical Pharmacy Continuing Education Program in Turkey
SANCAR M., OKUYAN B., RABUŞ Ş., SOYDEĞER B., İZZETTİN F. V.
9th International Symposium on Pharmaceutical Sciences, 23 - 26 Haziran 2009
2009
2009113. A Turkish Vision for Clinical Pharmacy Practice and Education
RABUŞ Ş.
Clinical Pharmacy Seminar, Marmara University, İstanbul, Türkiye, 12 Mayıs 2009, (Tam Metin Bildiri)
2009
2009114. Impact of a continuous professional development program on the counseling practices and attitudes of the pharmacists about emergency contraceptive pills
RABUŞ Ş., İZZETTİN F. V.
2009 ACCP/ESCP International Congress on Clinical Pharmacy, Orlando, Florida, Amerika Birleşik Devletleri, 24 - 28 Nisan 2009, (Özet Bildiri)
2009
2009115. A prospective assessment of therapeutic efficacy and immune effects of levofloxacin and ofloxacin in multiple drug resistant tuberculosis
Clark P., RABUŞ Ş., Kiran B., Karagoz T., İZZETTİN F. V.
2009 ACCP/ESCP International Congress on Clinical Pharmacy, Orlando, Florida, Amerika Birleşik Devletleri, 24 - 28 Nisan 2009, (Özet Bildiri)
2009
2009116. Assessment of quality of diabetes care for type 2 diabetics
RABUŞ Ş., Hursitoglu M., Bulgurlu S., Dayan A., Yolcu N., Gebologlu N., et al.
2009 ACCP/ESCP International Congress on Clinical Pharmacy, Orlando, Florida, Amerika Birleşik Devletleri, 24 - 28 Nisan 2009, (Özet Bildiri)
2009
2009117. Effects of Nigella Sativa oil on cutaneous wound healing in rats
İZZETTİN F. V., Varol Y., RABUŞ Ş., Cevikbas A.
2009 ACCP/ESCP International Congress on Clinical Pharmacy, Orlando, Florida, Amerika Birleşik Devletleri, 24 - 28 Nisan 2009, (Özet Bildiri)
2009
2009118. Effect of topical insulin on cutaneous wound healing in non diabetic and acute diabetic rats
RABUŞ Ş., İZZETTİN F. V., Turan P., Ercan F.
2009 ACCP/ESCP International Congress on Clinical Pharmacy, Amerika Birleşik Devletleri, 24 - 28 Nisan 2009, (Özet Bildiri)
2009
2009119. Patient Education in Diabetes Mellitus
RABUŞ Ş.
Seminar on Management of Diabetes Mellitus - Patient Focused Approaches, Yeditepe University, İstanbul, Türkiye, 20 Nisan 2009, (Tam Metin Bildiri)
2008
2008120. Assesment of energy drink and vitamin mineral combination supplement utilization profile of athletes
AYÇA İ. B., RABUŞ Ş.
10th International Sports Sciences Congress, Bolu, Türkiye, 23 - 25 Ekim 2008, (Tam Metin Bildiri)
2008
2008121. Assessment of energy drink and vitamin mineral combination supplement utilization profile of athletes
Ayca B., RABUŞ Ş.
10th International Sport Sciences Congress, Bolu, Türkiye, 23 - 25 Ekim 2008, (Özet Bildiri)
2007
2007122. Assesment of drug Utilization Profiles Attitudes and Knowledge on Performance Enhancing Drugs Among Players of the Amateur Football League
Ayça İ. B., Rabuş Ş.
36th European Symposium on Clinical Pharmacy, İstanbul, Türkiye, 25 - 27 Ekim 2007, (Özet Bildiri)
2007
2007123. Assessment of drug utilization profiles attitudes and knowledge on performance enhancing drugs among players of the amateur football league
Ayca B., RABUŞ Ş.
36th European Symposium on Clinical Pharmacy, İstanbul, Türkiye, 25 - 27 Ekim 2007, (Özet Bildiri)
2007
2007124. Cardiovascular drugs prescription profiles and the economic impact of a generic based reimbursement system
cinemreSolmaz N., Burat K., RABUŞ Ş.
36th European Symposium on Clinical Pharmacy, İstanbul, Türkiye, 25 - 27 Ekim 2007, (Özet Bildiri)
2007
2007125. Fourth grade pharmacy students prefer kinesthetic learning
RABUŞ Ş., İZZETTİN F. V.
36th European Symposium on Clinical Pharmacy, İstanbul, Türkiye, 25 - 27 Ekim 2007, (Özet Bildiri)
2007
2007126. The economic impact of a generic substitution based reimbursement system for type 2 diabetes
RABUŞ Ş., yurtseven S., Guler O., Soydeger Carli B., RABUŞ M. B., demircioglu S., et al.
7th ESCP Spring Conference, Edinburgh, Saint Helena, 16 - 19 Mayıs 2007, (Özet Bildiri)
2007
2007127. Quality of life in patients with tuberculosis
İZZETTİN F. V., Eminzade S., RABUŞ Ş., Karagoz T.
7th ESCP Spring Conference, Edinburgh, Saint Helena, 16 - 19 Mayıs 2007, (Özet Bildiri)
2006
2006128. Patient counseling practices and attitudes of pharmacy staff and pharmacy students on emergency contraception pills
RABUŞ Ş., Dincer A., Donmez F., Ekiz A., Guler O., Reiazi B., et al.
Proceedings: 6th ESCP Spring Conference - Chronic Disease Management: the Role of the Pharmacist Vilnius, Lithuania, 25-27 May 2006., Vilniaus, Litvanya, 25 - 27 Mayıs 2006, (Özet Bildiri)
2006
2006129. Mid-term results of secondary prevention in coronary artery disease: drug utilization profiles.
RABUŞ Ş., İZZETTİN F. V., SANCAR M., Karakaya O., Kargin R., Yakut C.
Proceedings: 6th ESCP Spring Conference - Chronic Disease Management: the Role of the Pharmacist, Vilniaus, Litvanya, 25 - 27 Mayıs 2006, (Özet Bildiri)
2006
2006130. Prevalence of patient reported adverse effects of statins particular emphasis on myalgia
RABUŞ Ş., Bozkurt E., Demircioglu C., Tandogan S., Aydın S., Uzel G., et al.
Proceedings: 6th ESCP Spring Conference - Chronic Disease Management: the Role of the Pharmacist Vilnius, Lithuania, 25-27 May 2006., Vilniaus, Litvanya, 25 Mayıs 2006 - 27 Mayıs 2066, (Özet Bildiri)
2007
2007131. Community pharmacists opinion on pharmaceutical care practice in Turkey
SANCAR M., OKUYAN B., RABUŞ Ş., İZZETTİN F. V.
7th ESCP Spring Conference: Tackling Inequalities in the Delivery of Pharmaceutical Care, 16 - 19 Mayıs 2007, cilt.31, ss.40-141
2005
2005132. Massive Creatine Kinase Increase during Quetiapine and Mirtazapine Treatment
RABUŞ Ş., İZZETTİN F. V., RABUŞ M. B., Bilici M.
34th European Symposium on Clinical Pharmacy, Amsterdam, Hollanda, 26 - 29 Ekim 2005, ss.460, (Özet Bildiri)
2005
2005133. Cardiovascular Drug Prescription in Type 2 Diabetes
İZZETTİN F. V., RABUŞ Ş., SANCAR M., Gebologlu N., Hursitoglu M.
34th European Symposium on Clinical Pharmacy, Amsterdam, Hollanda, 26 - 29 Ekim 2005, ss.513, (Özet Bildiri)
2004
2004134. Outcomes of pharmaceutical care in type 2 diabetes patient education and monitoring
Turnacilar M., SANCAR M., RABUŞ Ş., Izzettin N., Turnacilar E., İZZETTİN F. V.
33rd European Symposium on Clinical Pharmacy, Prague, Çek Cumhuriyeti, 20 - 23 Ekim 2004, ss.13, (Özet Bildiri)
2004
2004135. Prescription profiles in primary and secondary coronary artery disease prevention
RABUŞ Ş., SANCAR M., Eskisar A., Turan F., Yakut C., İZZETTİN F. V.
33rd European Symposium on Clinical Pharmacy, Prague, Çek Cumhuriyeti, 20 - 23 Ekim 2004, ss.103, (Özet Bildiri)
2004
2004136. Predictors of coronary artery disease in Turkish subjects
İZZETTİN F. V., RABUŞ Ş., Mutlu B., Basaran Y., Yakut C.
33rd European Symposium on Clinical Pharmacy, Prague, Çek Cumhuriyeti, 20 - 23 Ekim 2004, ss.84, (Özet Bildiri)
2004
2004137. Improvement of pharmacists knowledge with continuing education programs
DEMİRKAN S. K., Yılmaz D., SANCAR M., İZZETTİN F. V., RABUŞ Ş.
2nd Joint Meeting ESCP-ACCP, Paris, Fransa, 28 - 30 Nisan 2004, ss.13, (Özet Bildiri)
2003
2003138. ”Pharmacist’s role in management of upper respiratory tract infections” Üst solunum yolları enfeksiyonlarının tedavisinde eczacının rolü
İZZETTİN F. V., SANCAR M., RABUŞ Ş.
International Symposium on Pharmaceutical Sciences, Ankara, Türkiye, 27 Haziran 2003
2002
2002139. Cost effectiveness of tissue plasminogen activator vs streptokinase a hospital study in Turkey
RABUŞ Ş., İZZETTİN F. V., RABUŞ M. B., YAKUP C.
31st European Symposium on Clinical Pharmacy, Florence, İtalya, 30 Ekim - 02 Kasım 2002, ss.81, (Özet Bildiri)
2002
2002140. Karar Ağacı
RABUŞ Ş.
Yöneticilere Farmakoekonomik Bakış Açısı Kazandırma2, İstanbul, Türkiye, 26 - 27 Eylül 2002, (Tam Metin Bildiri)
2019
2019141. ”Essentials of diabetes for pharmacists” Diyabet hakkında eczacının bilmesi gerekenler
RABUŞ Ş.
2. Marmara Klinik Eczacılık Günleri, İstanbul, Türkiye, 14 Mayıs 2019 - 14 Mayıs 1029, (Özet Bildiri)
Kitaplar
2020
20201. İlaç-İlaç Etkileşimlerinin Yönetimi, COVID -19 Tedavisine Bağlı QT Uzaması ve Yönetimi, COVID-19 Tedavisinde Potansiyel İlaç-İlaç Etkileşimleri
ENVER C., AYHAN Y. E., DEMİRCİ M. Y., ÜNDER D., ÖZGAN B., İLERLER E. E., et al.
SAĞLIK ÇALIŞANLARI İÇİN COVID-19 PANDEMİSİNDE İLAÇ YÖNETİMİ VE GÜVENLİ İLAÇ UYGULAMALARI, SANCAR MESUT, Editör, Türk Eczacıları Birliği, Ankara, ss.1-96, 2020
2013
20132. İlaç Güvenliği
İZZETTİN F. V., RABUŞ Ş., OKUYAN B., SANCAR M.
Hastane Yönetimi, Haydar Sur, Tunçay Palteki, Editör, Nobel Tıp Kitabevleri, ss.561-576, 2013
2012
2012